Home
News
Create
Screeners
Insights
Anlon Healthcare
15.
05
-0.34
(-2.21%)
Market Cap
₹799.93 Cr
PE Ratio
28.05
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-2.21%
1M
-1.25%
6M
+9.93%
1Y
-83.59%
5Y
-83.59%
View Company Insights
Latest news about Anlon Healthcare
Anlon Healthcare incorporates Anlon Biologics to expand biologics
3 days ago
Anlon Healthcare Ltd incorporated a new subsidiary, Anlon Biologics Private Limited, on July 10, 2026, to develop and manufacture peptides, biosimilars, and biological compositions. The subsidiary has an authorized and paid-up share capital of Rs. 1,000,000 and is yet to commence business operations. Anlon Healthcare holds a 65% stake in the entity, subscribing to 65,000 equity shares for an aggregate consideration of Rs. 650,000 via cash and banking channels.
Anlon Healthcare CMD outlines growth strategy in interview
7 days ago
Anlon Healthcare approves two new subsidiaries to expand portfolio
Jul 02, 2026
Anlon Healthcare reports Q1FY26 net profit of ₹354.69 lakh
Jun 26, 2026
Anlon Healthcare CMD to discuss FY26 on NDTV Profit
Jun 12, 2026
More news about Anlon Healthcare
10
Jun 26
Anlon Healthcare FY26 PAT rises 42% to ₹29.09 crore
Anlon Healthcare reported a 42.98% YoY rise in consolidated total income to ₹172.22 crore for FY26, with PAT growing 41.77% to ₹29.09 crore. EBITDA increased 47.55% to ₹47.77 crore. The company completed acquisitions of Apiqo Organics and Bizotic Life Science, expanding capacity to 1400-1600 MTPA. Management guided for FY27 revenue of ₹380-400 crore and expects to be cash flow positive by FY27-end.
04
Jun 26
Anlon Healthcare FY26 PAT rises 42% to ₹29.09 crore
Anlon Healthcare reported a 42.98% rise in consolidated total income to ₹172.22 crore for FY26, with net profit increasing to ₹29.09 crore. Q4FY26 total income stood at ₹50.90 crore. The company highlighted strategic acquisitions and capacity expansion in its investor presentation.
Anlon Healthcare
15.
05
-
0.
34
(-
2.
21
%)
1 Year Returns:
-83.59%
Industry Peers
Sun Pharmaceutical
1,942.60
(+
1.
10
%)
Divis Laboratories
7,188.50
(+
3.
60
%)
Torrent Pharmaceuticals
4,973.50
(+
0.
45
%)
Cipla
1,438.10
(+
0.
80
%)
Zydus Life Science
1,133.60
(+
0.
20
%)
Lupin
2,469.20
(-
0.
94
%)
Mankind Pharma
2,531.10
(+
0.
94
%)
Dr Reddys Laboratories
1,246.20
(+
0.
95
%)
Aurobindo Pharma
1,552.80
(+
0.
23
%)
Laurus Labs
1,560.70
(+
0.
13
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar